How to Buy Pfizer Stock
Pfizer Inc
Pfizer is a general drug manufacturer company located in New York, United States, which is part of the Healthcare sector, and is traded under the ticker PFE on the NYSE exchange.
Pfizer stock last closed at $28.64, down 0.97% from the previous day, and has decreased 22.07% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.4 percentage points. Pfizer stock is currently +13.65% from its 52-week low of $25.20, and -29.05% from its 52-week high of $40.37.
As of May 17, 2024, there are 5.67B shares of PFE outstanding. The market cap of PFE is $162.29B. In the last 24 hours, 25.66M PFE shares were traded.
How to Buy Pfizer Stock
Wondering how to invest in Pfizer stock? Here's how.
- Figure out where to buy Pfizer stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Pfizer stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your payment method and add your information.
- Analyze Pfizer stock: The Pfizer ticker symbol is PFE. Is Pfizer stock a good investment? Should you buy shares of PFE? How do PFE's underlying business fundamentals look? Do top analysts think Pfizer is a good buy? Why has PFE's stock price moved recently? (Hint: Our stock research website can help you understand if PFE is a good stock to buy).
- Make your PFE trade: Decide if you will purchase PFE shares at the current market price or use a limit order to purchase PFE shares at a particular price.
- Get the latest scoop on your PFE position: Create a watchlist to keep track of your investment in Pfizer stock.
Step 1: Figure out where to buy Pfizer stock
You will need an online brokerage account to access the NYSE market and buy PFE stock.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal info so you are able to invest in PFE today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to start your new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have filled out your info on one of the most highly reviewed stock trading apps, you can securely and quickly fund your account:
Watch the walkthrough below for more details transferring funds into your new investment account.
Step 4: Analyze Pfizer stock
After you have figured out the best place to buy Pfizer stock, it's very important to research their stock prior to investing, so you truly understand the risk as well as the upside.
Pfizer shares data
PFE Due Diligence Checks
WallStreetZen was created to help everyday investors do more accurate fundamental analysis.
You can view all of the due diligence checks on PFE's stock page.
What is the fair value of PFE stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge PFE's intrinsic value.
Using relative valuations metrics:
- PFE could be undervalued based on its P/B ratio of 1.76x, relative to Drug Manufacturers - General industry P/B ratio of 6.42x
You can do more valuation research on PFE's stock here.
Is PFE a healthy company?
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the PFE balance sheet.
- Total PFE debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- PFE earnings of -$1.85B is not enough to cover its interest payments.
- PFE's operating cash flow of $8.58B allows it to safely service it's debt of $69.54B.
- PFE has a relatively high debt to equity ratio of 1.39.
- There are more long-term liabilities than short-term assets on the PFE balance sheet.
- PFE profit margin has gone down from 31.2% to -0.6% in the past year.
Is it a good time to buy Pfizer stock, according to Wall Street analysts?
Out of 8 Wall Street analysts who monitor PFE, the consensus analyst rating on Pfizer is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they investment advice.
Most Recent PFE Analyst Forecasts
Robyn Karnauskas, a bottom 6% analyst from Truist Securities maintains PFE with a strong buy rating and lowers their PFE price target from $42.00 to $36.00, on Dec 14, 2023.
Truist Securities's Robyn Karnauskas lowered their price target on Pfizer (NYSE: PFE) by 14.3% from $42 to $36 on 2023/12/14. The analyst maintained their Strong Buy rating on the stock.
Management's cautious $8B COVID-19 product prediction was a significant factor in Pfizer's lower-than-expected FY 2024 guidance update, Karnauskas said following the company's 2023/12/13 dated FY 2024 Guidance report.
However, Truist Securities believes that investing in oncology through the acquisition of Seagen will lead to long-term growth for Pfizerm the analyst reported.
Seagen offers Pfizer a wide variety of "proven and promising" options for antibody-drug conjugates, which are another cornerstone of cancer treatment, Karnauskas explained.
Footnotes
In its update, Pzifer guided for FY 2024:
- Revenue of $58.5B to $61.5B, up from the previously guided $54.5B to $57.5B.
- EPS of $2.05 to $2.25, down 15.7% at the midpoint from the previously guided $2.45 to $2.65.
Making the announcement, Chairman & CEO Dr. Albert Bourla said: “Pfizer’s product portfolio remains strong.
"In 2024, Comirnaty and Paxlovid are expected to deliver combined revenues of approximately $8 billion and our remaining portfolio of combined Pfizer and Seagen products is expected to achieve year-over-year operational revenue growth in the range of 8% to 10%.
“In addition, we expect our cost realignment program to deliver savings of at least $4.0 billion by the end of 2024, which puts us on a path to potentially regain our pre-pandemic operating margins.
“We look forward to joining forces with Seagen and using our combined strengths to bring us ever closer to delivering long-promised cures for certain cancers.”
Colin Bristow, a bottom 15% analyst from UBS maintains PFE with a hold rating and lowers their PFE price target from $34.00 to $27.00, on Dec 14, 2023.
Carter Gould, a top 19% analyst from Barclays maintains PFE with a hold rating and lowers their PFE price target from $34.00 to $28.00, on Dec 14, 2023.
You can dive deeper into what analysts are forecasting on the Pfizer stock forecast page.
Metrics for Advanced PFE Traders
PFE Performance Numbers
Last year, PFE revenue was $55.09B. During the past five year, PFE's revenue has grown by 6.07% per year. This was slower than the Drug Manufacturers - General industry average of 7.29%.
Dive into PFE's earnings and revenue performance here.
Latest Insiders Trades at PFE
In the last year, insiders at PFE have sold more shares than they have bought.
Christoffel Boshoff, Executive Vice President of PFE, was the latest PFE insider to sell. They sold $112,216.00 worth of PFE stock on Feb 28, 2024.
Dig into more about who owns PFE shares here.
Can I rely on PFE as an income stream?
Pfizer pays a dividend of 5.8%, compared to the Drug Manufacturers - General industry's average dividend yield of 3.56%. If you owned $1,000 of PFE stock, you would have been paid $57.96 in the past 12 months.
Pfizer dividend payments have consistently grown over the past decade and have remained stable.
Get more analysis about Pfizer dividend yield and history here.
What others are saying about PFE
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Make your PFE trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at an exact dollar amount, place a limit order.
Click the Open Trade button and eToro will execute the order.
If you need additional assistance buying stocks on eToro, watch the how to video below:
Step 6: Get the latest scoop on your PFE position
Now that you own some shares in PFE, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to track the most important metrics related to your PFE stock.
PFE Feed
How to Buy Stock in Pfizer
To summarize, here are the 6 steps you need to take to buy Pfizer stock right now:
- Figure out where to buy Pfizer stock
- Create your brokerage account
- Fund your investment account
- Analyze Pfizer stock
- Make your PFE trade
- Get the latest scoop on your PFE position
If you are looking for a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get the latest news on your new investment in Pfizer, create a watchlist today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.